There’s No Place Like Home — for Dialysis

New home hemodialysis systems are easier for kidney disease patients to useHighlights• Home hemodialysis could allow patients to enjoy increased freedom, quality of life, greater ability to travel, and tangible health improvements. • Increased physician and patient education can eliminate barriers to home hemodialysis and increase its use.Approximately 2 million patients in the world receive some sort of dialysis treatment.

Newswise — Washington, DC (October 4, 2012) — Most patients with chronic kidney disease who undergo hemodialysis put up with a grueling treatment regimen that involves going into a clinic several days a week and sitting through a three-to-four hour dialysis session at each visit. Home hemodialysis is more accessible than ever, though, with the advent of newer systems that are easier for patients to learn, use, and maintain, according to a review appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The authors offer suggestions for how to overcome barriers and establish a successful home hemodialysis program.

“There is virtually no other disease that requires patients to make such considerable changes in their lifestyle as a diagnosis of end-stage renal disease and the need for dialysis therapy does,” said Rajnish Mehrotra, MD (University of Washington, Seattle). “To ease the challenge associated with such a diagnosis, offering patients choice allows them to select a dialysis therapy that best fits into their lifestyle and their expectations.”

Home hemodialysis is one type of dialysis therapy, but it is available to less than 2% of dialysis patients in the country. Home hemodialysis requires extensive patient training, nursing education, and infrastructure support to maintain a successful program. Also, reluctance to start such programs is widespread because many physicians do not have experience with home hemodialysis.

Bessie Young, MD (University of Washington, Seattle) worked with Dr. Mehrotra and others to provide an in-depth review to describe the benefits and barriers to home hemodialysis, focusing on patients, physicians, practices, and dialysis facilities.

Benefits of home hemodialysis include:

• Potential for greater dialysis delivery (more frequent or overnight treatments)• Improved quality of life• Patient independence and employment potential• Greater ability to travel• 20%-50% less costly than in-center hemodialysis depending on the machine.

Barriers to home hemodialysis include:

• Lack of patient awareness and education about home hemodialysis• Patients’ perceptions, including fear of change and lack of self-confidence• Physicians’ education about home hemodialysis• Machine complexity, which is now minimal with newer, easier-to-use systems• Inadequate payment to providers for home hemodialysis training.

“Home hemodialysis has been successfully used by thousands of patients and should be available to everyone on or initiating dialysis. It is a safe, efficient modality that allows patients the ability to increase their frequency of dialysis, which may provide a potential survival benefit,” said Dr. Young.

Study co-authors include Christopher Chan, MD, Christopher Blagg, MD, Robert Lockridge, MD, Thomas Golper, MD, Fred Finkelstein, MD, Rachel Shaffer, and Rajnish Mehrotra on behalf of the ASN Dialysis Advisory Group (DAG).

Disclosures: Christopher Chan serves as a member of the scientific advisory board for Baxter Healthcare. Christopher Blagg is a consultant to DEKA Research and Development Corporation. Robert Lockridge serves as a member of the scientific advisory board for Fresenius Medical Care. Thomas Golper conducts consultant activity for Baxter, Fresenius, DaVita, Takeda-Affymax, and Q Source. Fredric Finkelstein serves as a member of the scientific advisory board for NxStage and conducts consultant activity for Baxter Healthcare. Rachel Shaffer is an employee of the American Society of Nephrology. Rajnish Mehrotra has received grant support and/or honoraria from Baxter Healthcare, DaVita, Mitsubishi, Shire, Takeda, and Vifor.

The article, entitled “How to Overcome Barriers and Establish a Successful Home HD Program,” will appear online at http://cjasn.asnjournals.org/ on October 4, 2012, doi: 10.2215/CJN.07080712.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.# # #